Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Biorepository for Discovering Novel Biochemical and Genetic Markers of Coronary Heart Disease in Qatar (QCBio)

NCT03427489 is registered in ClinicalTrials.gov with Hamad Medical Corporation as lead sponsor.

NCT NCT03427489
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03427489 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Biorepository for Discovering Novel Biochemical and Genetic Markers of Coronary Heart Disease in Qatar (QCBio)
Lead sponsor
Hamad Medical Corporation
Phase
Observational
Overall status
Completed
Start date
January 31, 2013
Completion date
March 18, 2018
Enrollment
2,100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary heart disease (chd)